Command Palette

Search for a command to run...

cian-healthcare

5.54+1.84%
Market Cap
₹13.60 Cr
Stock P/E
53.49
ROCE
5.94%
ROE
0.58%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Growth Outperformer

Cian Healthcare Ltd. shows significant potential for growth despite current challenges, particularly in EPS growth, while being overshadowed by peers in profitability and valuation metrics. It presents a unique investment opportunity for those willing to take on higher risk for possible future returns.

Key Points
  • Cian Healthcare Ltd. has impressive EPS growth of 64.85% over three years, indicating strong potential despite current revenue decline.
  • The company has the lowest PBV at 0.2052, making it a potential deep value pick for investors.
  • High debt levels (1.4021) relative to peers could pose risks, but efficient cash flow metrics suggest operational viability.
Top Performers
Mankind Pharma Ltd.

Highest revenue growth YoY (18.12%) and strong profitability with high ROE (23.15%) and low debt (0.021).

Dr. Reddy's Laboratories Ltd.

Strong profitability metrics with high ROE (21.76%) and attractive valuation (PE of 15.50).

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.